Cephalon wins U.S. approval for leukemia drug (Reuters)
Date : 2008 03 20 Category : Health
Reuters - Cephalon Inc won U.S. approval to
sell a chemotherapy drug to treat patients with chronic
lymphocytic leukemia (CLL), the company said on Thursday.